NASDAQ
CHEK

Check Cap Ltd

Diagnostics & Research
Healthcare

Prices are adjusted according to historical splits.

Check Cap Ltd Stock Price

Vitals

Today's Low:
$1.22
Today's High:
$1.35
Open Price:
$1.33
52W Low:
$1.22
52W High:
$9.198
Prev. Close:
$1.31
Volume:
90189

Company Statistics

Market Cap.:
$7.66 million
Book Value:
7.714
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-24.29%
Return on Equity TTM:
-41.39%

Company Profile

Check Cap Ltd had its IPO on 2015-02-19 under the ticker symbol CHEK.

The company operates in the Healthcare sector and Diagnostics & Research industry. Check Cap Ltd has a staff strength of 81 employees.

Stock update

Shares of Check Cap Ltd opened at $1.33 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $1.22 - $1.35, and closed at $1.32.

This is a +0.76% increase from the previous day's closing price.

A total volume of 90,189 shares were traded at the close of the day’s session.

In the last one week, shares of Check Cap Ltd have slipped by -56%.

Check Cap Ltd's Key Ratios

Check Cap Ltd has a market cap of $7.66 million, indicating a price to book ratio of 0.3628 and a price to sales ratio of 0.

In the last 12-months Check Cap Ltd’s revenue was $0 with a gross profit of $0 and an EBITDA of $-21077000. The EBITDA ratio measures Check Cap Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Check Cap Ltd’s operating margin was 0% while its return on assets stood at -24.29% with a return of equity of -41.39%.

In Q3, Check Cap Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Check Cap Ltd’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-1.75 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Check Cap Ltd’s profitability.

Check Cap Ltd stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 1.3492. Its price to sales ratio in the trailing 12-months stood at 0.

Check Cap Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$49.55 million
Total Liabilities
$3.83 million
Operating Cash Flow
$1.93 million
Capital Expenditure
$72000
Dividend Payout Ratio
0%

Check Cap Ltd ended 2023 with $49.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $49.55 million while shareholder equity stood at $44.93 million.

Check Cap Ltd ended 2023 with $0 in deferred long-term liabilities, $3.83 million in other current liabilities, 83653000.00 in common stock, $-123580000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.35 million and cash and short-term investments were $45.60 million. The company’s total short-term debt was $353,000 while long-term debt stood at $0.

Check Cap Ltd’s total current assets stands at $46.54 million while long-term investments were $0 and short-term investments were $36.25 million. Its net receivables were $0 compared to accounts payable of $849000.00 and inventory worth $0.

In 2023, Check Cap Ltd's operating cash flow was $1.93 million while its capital expenditure stood at $72000.

Comparatively, Check Cap Ltd paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
$1.32
52-Week High
$9.198
52-Week Low
$1.22
Analyst Target Price
$15

Check Cap Ltd stock is currently trading at $1.32 per share. It touched a 52-week high of $9.198 and a 52-week low of $9.198. Analysts tracking the stock have a 12-month average target price of $15.

Its 50-day moving average was $3.2 and 200-day moving average was $4.86 The short ratio stood at 0.35 indicating a short percent outstanding of 0%.

Around 320.6% of the company’s stock are held by insiders while 168.2% are held by institutions.

Frequently Asked Questions About Check Cap Ltd

The stock symbol (also called stock or share ticker) of Check Cap Ltd is CHEK

The IPO of Check Cap Ltd took place on 2015-02-19

Similar Industry Stocks (Diagnostics & Research)

Last Price
Chg
Chg%
$1.18
-0.04
-3.16%
$10.3
0
0%
$0.12
0.01
+6.38%
$44.57
-0.91
-2%
$6.23
0.01
+0.16%
$3.65
0.11
+3.11%
$0.12
-0.01
-5.38%
$7.37
0.15
+2.08%
$0.7
-0
-0.16%
$0.12
0
0%

Most Active

Last Price
Chg
Chg%
$0
0
0%
$0
0
+75%
$0.11
-0
-1.18%
$0
-0
-33.33%
$1.72
0.59
+52.21%

Top Gainers

Last Price
Chg
Chg%
$0
0
+58723.53%
$0
0
+20460.42%
$0.63
0
+2548.22%
$0.02
0
+1566.67%

Top Losers

Last Price
Chg
Chg%
$0.16
-130.01
-99.88%
NGC-WT (NGC-WT)
$0
-0.04
-94.66%
$4.7
-33.3
-87.63%
Imara Inc (IMRA)
$21
0
-78.71%

About

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient’s back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Address

Check-Cap Building, Isfiya, Israel, 30090